Biostate AI closes $12M to bring the Netflix model to molecular diagnostics
Posted:
Biostate AI, a leading innovator in artificial intelligence and RNA sequencing, announced the successful completion of a $12M Series A funding round, led by Accel. The company’s immediate focus is revolutionizing RNAseq accessibility and developing clinically relevant predictive models.
Technical debt comes in many forms, especially for hospitals and health systems. The larger the organization, the more complex the technology, explains David Hotchkiss, vice president and chief information and security officer for the Medical College of Wisconsin.
Read more here.
Learn how the MHRA and NICE are getting medicines to patients 3 to 6 months sooner by delivering same time decisions on licensing and value.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us